Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients




The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

Leave a Reply

Your email address will not be published. Required fields are marked *